Ge healthcare receives fda clearance of a new deep learning solution for enhanced image quality in pet/ct, advancing its leadership position in ai

Chicago--(business wire)--ge healthcare (nasdaq: gehc) today announced us fda 510(k) clearance of precision dl – a new, revolutionary deep learning-based image processing software included in ge healthcare's growing effortless recon dl portfolio. precision dl provides the image quality performance benefits typically associated with hardware-based time-of-flight (tof) reconstruction, including improved contrast-to-noise ratioi, contrast recoveryi, and quantitative accuracyii. the ai-based techno.
GEHC Ratings Summary
GEHC Quant Ranking